CVR: 42886866
Secondary names: Kiox Pharma ApS, Kiox Therapeutics ApS
DKK 120,473
Gross profit
Net result: DKK -639,537
HELLERUNG ApS, Titi14 HOLDING ApS
1 more
CVR · view ownership and management
Owner registered: HELLERUNG ApS
CVR · 23/03/2026
View the full event history
Kiox Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2021. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Tim Dehli Carstensen and Mikkel Walmar. The company is owned by HELLERUNG ApS, Titi14 HOLDING ApS and 26c Holding ApS. In 2025, the company reported a gross profit of DKK 120,473 and a net result of DKK -639,537 compared with DKK -1,841,030 the year before. Equity in the 2025 report amounted to DKK -404,366.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringKiox Pharmaceuticals ApS was founded on 7 December 2021.
Kiox Pharmaceuticals ApS is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (industry code 749990).
Kiox Pharmaceuticals ApS is owned by HELLERUNG ApS, Titi14 HOLDING ApS and 26c Holding ApS.
In 2025, Kiox Pharmaceuticals ApS reported a gross profit of DKK 120,473.
The management of Kiox Pharmaceuticals ApS consists of Tim Dehli Carstensen and Mikkel Walmar.
Kiox Pharmaceuticals ApS is located at Stolbjergvej 26C, 3070 Snekkersten.
Claim this page to add your logo and social links. Free to get started.
Kiox Pharmaceuticals ApS has published its annual report for 2025. Gross profit came to DKK 120,473, and the net result was DKK -639,537.
Contact info changed: new email: [email protected] (June 30, 2026).
Contact info changed: new email: [email protected] (June 12, 2026).
Contact info changed: new email: [email protected] (March 24, 2026).
As of March 23, 2026, Inge Tarnow has joined the board of directors of Kiox Pharmaceuticals ApS.
As of March 23, 2026, Lars Hellerung Christiansen has joined the board of directors of Kiox Pharmaceuticals ApS.
As of March 23, 2026, Mikkel Walmar has joined the board of directors of Kiox Pharmaceuticals ApS.
As of March 23, 2026, HELLERUNG ApS is registered as an owner of Kiox Pharmaceuticals ApS with an ownership share of 15%.
As of March 23, 2026, 26c Holding ApS is registered as an owner of Kiox Pharmaceuticals ApS with an ownership share of 50%.
Kiox Pharmaceuticals ApS has published its annual report for 2024. Gross profit came to DKK -411,764, and the net result was DKK -1,841,030.
Kiox Pharmaceuticals ApS has published its annual report for 2023. Gross profit came to DKK 412,113, and the net result was DKK -968,993.
As of February 5, 2024, Tim Dehli Carstensen is registered as director of Kiox Pharmaceuticals ApS.
As of February 5, 2024, Titi14 HOLDING ApS is registered as an owner of Kiox Pharmaceuticals ApS with an ownership share of 20%.
Kiox Pharmaceuticals ApS has published its annual report for 2022. Gross profit came to DKK -2,632, and the net result was DKK -2,887.
As of December 7, 2021, Mikkel Walmar is registered as director of Kiox Pharmaceuticals ApS.
Kiox Pharmaceuticals ApS was founded on December 7, 2021.
Companies in the same industry and area
CVR 33668430
CVR 38398989
CVR 31242223
CVR 41842423
CVR 33399049
